2359.HK 603259.SHG

Pharmaceutical outsourcing giant WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced on Thursday it will raise HK$7.65 billion ($975 million) by placing around 73.8 million new Hong Kong-listed shares at HK$104.27 per share, representing a 6.9% discount to the stock’s previous closing price of HK$112. The new shares account for about 16.01% of the company’s enlarged capital for its Hong Kong-listed stock and 2.51% of its total issued share capital.

WuXi AppTec said around 90% of the proceeds will be used to accelerate expansion of its global footprint and expand production capacity, while the remaining 10% will go toward general corporate purposes.

The share placement comes shortly after the company reported strong first-half results. Revenue for the six months through June rose 20.64% year-on-year to 20.8 billion yuan, while its net profit surged 95.46% to 8.29 billion yuan.

WuXi AppTec’s stock opened lower on Thursday and closed at HK$107.8 by the midday break, down 3.75%. The stock is up 90% year-to-date.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Damai sells concert tickets

Damai rides China’s offline leisure boom to bumper profits

The company’s dominance in live entertainment ticketing and IP franchises has turbocharged its revenue, despite persistent consumer complaints and monopolistic behavior Key Takeaways: Damai’s profit rose around 50% in the…